Glaucoma patients with significant cataract are being informed about the study and potential risks, all participants giving written informed consent and meeting the criteria will become eligibility for study entry. Participants meeting the eligible requirements will be randomized to Cataract Surgery combined with Kahook Dual Blade Glide (50 patients) or iStent Inject W (50 patients).
Age
0–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Only one eye per participant
Clinically significant cataract
Glaucoma or intraocular hypertension treated with one to four medications and no need for filtering glaucoma surgery at the time of study enrollment.
Open chamber angle with Schaffer grading three to four in at least two quadrants
You may not be if
Previous glaucoma surgery, including cyclodestructive procedures.
Selective Laser Trabeculoplasty (SLT) within 90 days prior to planned surgery.
Exudative age-related macular degeneration, proliferative diabetic retinopathy, clinically significant corneal dystrophy, other eye disease that affect intraocular eye pressure or visual field.
Unable to participate and make written consent due to another medical condition.
Clareo Health | iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment
